Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lubrizol to Invest $25M in Facility Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Lubrizol to Invest $25M in Facility Expansion

To continue providing dedicated support to its industry partners

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lubrizol has unveiled plans to invest more than $25 million in its Calvert City, KY manufacturing facility. The investment follows a recent $10 million expansion at the site to improve the company’s safety management standards and create a world class quality laboratory.  
 
The facility specializes in the production of Carbopol polymers and Pemulen polymeric emulsifiers. These polymers are used in consumer goods for the personal care, home care, and pharmaceutical markets. This expansion will include advanced, proprietary process technology that will allow the Calvert City facility to continue to provide Lubrizol’s partners with high quality products.
 
“In response to increasing market demand, this investment will enable us to expand production capacity and update our infrastructure at our Calvert City facility while continuously improving safety and quality,” said Deb Langer, senior vice president and general manager, Lubrizol Personal, Home and Healthcare. “The expansion is critical in allowing our team to continue to provide dedicated service and support to our global partners.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics